The leading market experts have placed a mean price target of $48.40 on CONMED Corporation (NASDAQ:CNMD) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.58 a share for the upcoming quarter and $1.87 for the current fiscal.
The technical analysis of CONMED Corporation plainly substantiates that the 50-day moving average of CONMED Corporation is $44.55, and stock is trading $-4.48 points away or -10.06% from its 50-day moving average of $44.55. Further it is trading $-1.80 or -4.30% away its 200-day moving average of $41.87. CONMED Corporation (NASDAQ:CNMD) 52-week high is $55.83 and the 52-week low is $35.51.
This explains if the stock moves $-15.76, it will post a 52-week high. In event of +12.84% decline, a 52-week low will be hit.
Taking the valuation aspect to emphasize the valuation of CONMED Corporation, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, CONMED Corporation (NASDAQ:CNMD) ratio came in at 64.73.
The stock last ended the trading session at $40.07 and registered a market cap of $1.11B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. CONMED Corporation (NASDAQ:CNMD) PEG ratio is at 2.43.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...